| Health / Medical Topics |
Davalintide
A second-generation, 32-amino acid peptide analogue of human amylin with antihyperglycemic activity. By mimicking amylin, davalintide, which has a half-life similar to amylin, slows gastric emptying, inhibits digestive secretions (gastric acid, pancreatic enzymes, and bile), reduces glucagon secretion, and increases satiety. These actions result in a decrease in blood glucose levels. Furthermore, davalintide exhibits high affinity binding to amylin, calcitonin and calcitonin-related peptide receptors. Compared to amylin, davalintide shows a prolonged duration of action due to its slowed receptor dissociation. (NCI Thesaurus)
YOU MAY ALSO LIKE
A complex comprised of Daunorubicin linked to DNA to enhance the topoisomerase II-mediated interaction with the DNA base pairs and reduce cardiotoxicity…
A drug used to treat acute leukemias and some other types of cancer. It blocks a certain enzyme needed for cell division…
A semi-synthetic anthracycline glycoside antibiotic obtained from Streptomyces with antineoplastic activity. Daunorubicin citrate intercalates DNA, which leads to inhibition of DNA and…
The active ingredient in a drug used to treat acute leukemias and some other types of cancer. It blocks a certain enzyme…
A drug used to treat acute leukemias and some other types of cancer. It blocks a certain enzyme needed for cell division…
The active ingredient in a drug used to treat acute leukemias and some other types of cancer. It blocks a certain enzyme…
